Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Smruthi Organics has informed that the Company has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM), Europe for its product Amlodipine Besilate. The CEP certifies that the quality of the substance complies with the requirements of the European Pharmacopoeia and enables the Company to supply this product to pharmaceutical manufacturers in European markets and other regions that recognize the CEP certification. This milestone strengthens the Company’s regulatory portfolio and enhances opportunities to expand its presence in regulated markets.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.65 |
| Dr. Reddys Lab | 1222.20 |
| Cipla | 1232.45 |
| Zydus Lifesciences | 928.45 |
| Lupin | 2322.30 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: